YU6703A - Ne-peptidni ccr1 receptor antagonisti u kombinaciji sa ciklosporinom a za tretman odbacivanja transplanta srca - Google Patents

Ne-peptidni ccr1 receptor antagonisti u kombinaciji sa ciklosporinom a za tretman odbacivanja transplanta srca

Info

Publication number
YU6703A
YU6703A YU6703A YUP6703A YU6703A YU 6703 A YU6703 A YU 6703A YU 6703 A YU6703 A YU 6703A YU P6703 A YUP6703 A YU P6703A YU 6703 A YU6703 A YU 6703A
Authority
YU
Yugoslavia
Prior art keywords
cyclosporin
transplant rejection
heart transplant
treatment
combination
Prior art date
Application number
YU6703A
Other languages
English (en)
Inventor
Richard Horuk
Original Assignee
Schering Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Aktiengesellschaft filed Critical Schering Aktiengesellschaft
Publication of YU6703A publication Critical patent/YU6703A/sh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13Cyclosporins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Transplantation (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Pronalazak je usmeren na farmaceutske sastave korisne u tretiranju odbacivanja transplanta srca kod sisara koji obuhvataju farmaceutski prihvatljivo vezivno sredstvo, terapeutski efektivnu količinu ne-peptidnog CCR1 receptor antagonista i sub-nefrotoksičnu količinu ciklosporina A.[This invention is directed to pharmaceutical compositions useful in treating heart transplant rejection in mammals comprising a pharmaceutically acceptable excipient, a therapeutically effective amount of a non-peptide CCR1 receptor antagonist and a sub-nephrotoxic amount of cyclosporin A.
YU6703A 2000-07-31 2001-07-31 Ne-peptidni ccr1 receptor antagonisti u kombinaciji sa ciklosporinom a za tretman odbacivanja transplanta srca YU6703A (sh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22205300P 2000-07-31 2000-07-31
US23128200P 2000-09-08 2000-09-08
US09/915,411 US6740636B2 (en) 2000-07-31 2001-07-25 Non-peptide CCR1 receptor antagonists in combination with cyclosporin A for the treatment of heart transplant rejection

Publications (1)

Publication Number Publication Date
YU6703A true YU6703A (sh) 2006-05-25

Family

ID=27397025

Family Applications (1)

Application Number Title Priority Date Filing Date
YU6703A YU6703A (sh) 2000-07-31 2001-07-31 Ne-peptidni ccr1 receptor antagonisti u kombinaciji sa ciklosporinom a za tretman odbacivanja transplanta srca

Country Status (28)

Country Link
US (1) US6740636B2 (sh)
EP (1) EP1305047B1 (sh)
JP (1) JP2004530630A (sh)
KR (1) KR20030048000A (sh)
CN (1) CN1655818A (sh)
AT (1) ATE330634T1 (sh)
AU (2) AU7807301A (sh)
BG (1) BG107502A (sh)
BR (1) BR0113140A (sh)
CA (1) CA2417636A1 (sh)
CY (1) CY1105321T1 (sh)
DE (1) DE60120986T2 (sh)
DK (1) DK1305047T3 (sh)
EE (1) EE200300047A (sh)
ES (1) ES2261447T3 (sh)
HR (1) HRP20030121A2 (sh)
HU (1) HUP0300686A3 (sh)
IL (1) IL153933A0 (sh)
LV (1) LV13033B (sh)
MX (1) MXPA03000836A (sh)
NO (1) NO20030475L (sh)
NZ (1) NZ523688A (sh)
PL (1) PL364521A1 (sh)
PT (1) PT1305047E (sh)
SI (1) SI21123A (sh)
SK (1) SK1222003A3 (sh)
WO (1) WO2002009762A2 (sh)
YU (1) YU6703A (sh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005018642A1 (en) * 2003-08-22 2005-03-03 Schering Aktiengesellschaft Chemokine inhibiting piperazine derivatives and their use to treat myocarditis
US10499828B2 (en) * 2004-03-05 2019-12-10 Lifescience Solutions, Llc System and method for heart monitoring
US7917195B2 (en) 2004-03-05 2011-03-29 Lifesciences Solutions LLC Systems, methods and computer program products for heart monitoring
US8103065B2 (en) * 2006-01-05 2012-01-24 Lifescience Solutions Llc Assessment of medical conditions
US20110009758A1 (en) * 2009-07-10 2011-01-13 Lifescience Solutions Llc System and method for heart monitoring

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6323206B1 (en) 1996-07-12 2001-11-27 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
KR100447553B1 (ko) 1997-02-26 2004-09-08 화이자 인코포레이티드 헤테로아릴-헥사노산 아미드 유도체, 그의 제조 방법 및 mip-1 알파의 ccr1 수용체로의 결합에 대한 선택적 저해제로서의 용도
US6207665B1 (en) * 1997-06-12 2001-03-27 Schering Aktiengesellschaft Piperazine derivatives and their use as anti-inflammatory agents
CA2319077A1 (en) 1998-01-21 1999-07-29 Yoshisuke Nakasato Chemokine receptor antagonists and methods of use therefor
US6433165B1 (en) 1998-01-21 2002-08-13 Millennium Pharmaceuticals, Inc. Chemokine receptor antagonists and methods of use therefor
CN1177834C (zh) 1998-02-05 2004-12-01 辉瑞产品公司 二羟基己酸衍生物
EP1000626A1 (en) 1998-09-18 2000-05-17 Applied Research Systems ARS Holding N.V. Chemokine receptor antagonist and cyclosporin in combined therapy
JP2002535358A (ja) 1999-01-29 2002-10-22 ミレニアム・ファーマシューティカルズ・インコーポレイテッド 移植片拒絶反応及び虚血−再灌流障害の予防方法

Also Published As

Publication number Publication date
JP2004530630A (ja) 2004-10-07
EP1305047B1 (en) 2006-06-21
CN1655818A (zh) 2005-08-17
HUP0300686A2 (hu) 2003-08-28
BG107502A (en) 2003-07-31
SK1222003A3 (en) 2003-09-11
CY1105321T1 (el) 2010-03-03
SI21123A (sl) 2003-08-31
BR0113140A (pt) 2003-06-24
LV13033B (en) 2004-02-20
IL153933A0 (en) 2003-07-31
EP1305047A2 (en) 2003-05-02
NZ523688A (en) 2005-04-29
CA2417636A1 (en) 2002-02-07
ES2261447T3 (es) 2006-11-16
HRP20030121A2 (en) 2005-02-28
PT1305047E (pt) 2006-11-30
ATE330634T1 (de) 2006-07-15
DK1305047T3 (da) 2006-10-23
MXPA03000836A (es) 2003-06-06
AU2001278073B2 (en) 2005-06-30
AU7807301A (en) 2002-02-13
EE200300047A (et) 2004-10-15
US6740636B2 (en) 2004-05-25
DE60120986T2 (de) 2006-11-23
US20020039997A1 (en) 2002-04-04
NO20030475L (no) 2003-03-28
WO2002009762A2 (en) 2002-02-07
NO20030475D0 (no) 2003-01-30
KR20030048000A (ko) 2003-06-18
WO2002009762A3 (en) 2003-01-09
DE60120986D1 (de) 2006-08-03
HUP0300686A3 (en) 2005-03-29
PL364521A1 (en) 2004-12-13

Similar Documents

Publication Publication Date Title
DK1255738T3 (da) Gonadotropin-frigivende hormonreceptor-antagonister og fremgangsmåder relateret dertil
TW200626572A (en) Heterocyclic derivatives and their use as therapeutic agents
AU3846901A (en) Oral, nasal and pulmonary dosage formualtions of copolymer 1
NZ514558A (en) Viral treatment
MXPA01008993A (es) Tratamiento de combinacion para depresion y ansiedad.
CY1105321T1 (el) Μη πεπτιδικοι ανταγωνιστες υποδοχεα ccr1 σε συνδυασμο με κυκλοσπορινη α για τη θepαπεια της απορριψης καρδιακου μοσχευματος
EP1213031A3 (en) Combination treatment for depression, anxiety and psychosis comprising an antidepressant and/or anxiolytic and a D4 receptor antagonist
IL154358A0 (en) Treatment of hiv-1 infection and inflammatory disease using cyclophilin receptor antagonists
CY1105302T1 (el) Μη-πεπτιδιο ανταγωνιστες υποδοχεα ccr1 για την θepαπεια προϊουσης νεφρικης ινωσης
MXPA04002389A (es) Combinacion de un antagonista del receptor de adenosian a2a y un antidepresivo o ansiolitico.
NO20013459D0 (no) Anvendelse av agiotensin II reseptorantagonister ved behandling av akutt myokardinfarkt
WO2000053148A3 (en) Methods and compositions for treating erectile dysfunction
EE200100689A (et) IL6RIL6 kimääri kasutamine ravimi valmistamiseks,mis on ette nähtud neuroloogiliste haiguste ravimiseks, ning farmatseutiline kompositsioon
LT2003015A (en) Non-peptide ccr1 receptor antagonists in combination with cyclosporin a for the treatment of heart transplant rejection
GB9930077D0 (en) Medicaments
BG105984A (bg) Използване на озанетант за приготвяне на лекарствени средства полезни за лечение на разстройства на настроението
EP2140864A3 (en) Use of GAL3 receptor antagonists for the treatment of depression and / or anxiety and compounds useful in such methods
EE04705B1 (et) Kemokiinretseptori antagonisti kasutamine kombinatsioonis tsüklosporiiniga farmatseutilise kompositsiooni valmistamiseks, mis on ette nähtud siirdatud organite, kudede või rakkude hülgamisreaktsiooniraviks või vältimiseks
AR018825A1 (es) Antagonistas del receptor de bradiquinina no peptidica para uso en el tratamiento de trastornos y enfermedades oftalmicas
SI1305047T1 (sl) Nepeptidni CCR1 receptorski antagonisti v kombinaciji s ciklosporinom A za zdravljenje zavrnitve srcnega transplantata